An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

Robert A. Scott(MRC Epidemiology Unit), Laura J. Scott(University of Michigan), Reedik Mägi(University of Tartu), Letizia Marullo(University of Ferrara), Kyle J. Gaulton(Centre for Human Genetics), Marika Kaakinen(Genomics England), Natalia Pervjakova(University of Tartu), Tune H. Pers(Statens Serum Institut), Andrew D. Johnson(National Heart Lung and Blood Institute), John D. Eicher(National Heart Lung and Blood Institute), Anne Jackson(University of Michigan), Teresa Ferreira(Centre for Human Genetics), Yeji Lee(University of Michigan), Clement Ma(University of Michigan), Valgerður Steinthórsdóttir(deCODE Genetics (Iceland)), Guðmar Þorleifsson(deCODE Genetics (Iceland)), Lu Qi(Brigham and Women's Hospital), Natalie R. van Zuydam(Centre for Human Genetics), Anubha Mahajan(Centre for Human Genetics), Han Chen(The University of Texas Health Science Center at Houston), Peter Almgren(Scania (Sweden)), Benjamin F. Voight(Translational Therapeutics (United States)), Harald Grallert(Helmholtz Zentrum München), Martina Müller‐Nurasyid(Helmholtz Zentrum München), Janina S. Ried(Helmholtz Zentrum München), Nigel W. Rayner(Centre for Human Genetics), Neil Robertson(Centre for Human Genetics), Lennart C. Karssen(Erasmus MC), Elisabeth M. van Leeuwen(Erasmus MC), Sara M. Willems(Erasmus MC), Christian Fuchsberger(University of Michigan), Phoenix Kwan(University of Michigan), Tanya M. Teslovich(University of Michigan), Pritam Chanda(Johns Hopkins University), Man Li(Johns Hopkins University), Yingchang Lu(Icahn School of Medicine at Mount Sinai), Christian Dina(Centre National de la Recherche Scientifique), Dorothée Thuillier(Centre National de la Recherche Scientifique), Loïc Yengo(Centre National de la Recherche Scientifique), Longda Jiang(Genomics England), Thomas Sparsø(University of Copenhagen), Hans A. Kestler(Universität Ulm), Himanshu Chheda(University of Helsinki), Lewin Eisele(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Stefan Gustafsson(Uppsala University), Mattias Frånberg(Stockholm University), Rona J. Strawbridge(Karolinska Institutet), Rafn Benediktsson(Reykjavík University), Ástráður B. Hreiðarsson(Reykjavík University), Augustine Kong(deCODE Genetics (Iceland)), Gunnar Sigurðsson(Reykjavík University), Nicola D. Kerrison(MRC Epidemiology Unit), Jian’an Luan(MRC Epidemiology Unit), Liming Liang(Harvard University), Thomas Meitinger(Helmholtz Zentrum München), Michael Roden(Deutsches Diabetes-Zentrum e.V.), Barbara Thorand(Helmholtz Zentrum München), Tõnu Esko(Broad Institute), Evelin Mihailov(University of Tartu), Caroline S. Fox(Brigham and Women's Hospital), Ching‐Ti Liu(Boston University), Denis Rybin(Boston University), Bo Isomaa(Folkhälsans Forskningscentrum), Valeriya Lyssenko(Scania (Sweden)), Tiinamaija Tuomi(University of Helsinki), David Couper(University of North Carolina at Chapel Hill), James S. Pankow(University of Minnesota), Niels Grarup(University of Copenhagen), Christian T. Have(University of Copenhagen), Marit E. Jørgensen(Steno Diabetes Centers), Torben Jørgensen(University of Copenhagen), Allan Linneberg(University of Copenhagen), Marilyn C. Cornelis(Northwestern University), Rob M. van Dam(Harvard University), Sarah Hunt(Brigham and Women's Hospital), Peter Kraft(Harvard University), Qi Sun(Brigham and Women's Hospital), Sarah Edkins(Wellcome Sanger Institute), Katharine R. Owen(Churchill Hospital), John R. B. Perry(MRC Epidemiology Unit), Andrew R. Wood(University of Exeter), Eleftheria Zeggini(Wellcome Sanger Institute), Juan Tajes-Fernandes(Centre for Human Genetics), Gonçalo R. Abecasis(University of Michigan), Lori L. Bonnycastle(National Institutes of Health), Peter S. Chines(National Institutes of Health), Heather M. Stringham(University of Michigan), Heikki A. Koistinen(University of Helsinki), Leena Kinnunen(University of Helsinki), Bengt Sennblad(Science for Life Laboratory), Thomas W. Mühleisen(University of Bonn), Markus M. Nöthen(University of Bonn), Sonali Pechlivanis(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Damiano Baldassarre(University of Milan), Karl Gertow(Karolinska Institutet), Steve E. Humphries(Cardiovascular Institute of the South), Elena Tremoli(University of Milan), Norman Klopp(Helmholtz Zentrum München), Julia Meyer(Helmholtz Zentrum München), Gerald Steinbach(Universität Ulm), Roman Wennauer(Erasmus MC), Johan G. Eriksson(University of Helsinki), Satu Männistö(Finnish Institute for Health and Welfare), Leena Peltonen(Broad Institute), Emmi Tikkanen(University of Helsinki), G. Charpentier(Centre Hospitalier Sud Francilien), Elodie Eury(Centre National de la Recherche Scientifique), Stéphane Lobbens(Centre National de la Recherche Scientifique), Bruna Gigante(Karolinska Institutet), Karin Leander(Karolinska Institutet), Olga McLeod(Karolinska Institutet), Erwin P. Böttinger(Icahn School of Medicine at Mount Sinai), Omri Gottesman(Icahn School of Medicine at Mount Sinai), Douglas M. Ruderfer(Icahn School of Medicine at Mount Sinai), Matthias Blüher(IFB Adiposity Diseases), Péter Kovács(IFB Adiposity Diseases), Anke Tönjes(IFB Adiposity Diseases), Nisa M. Maruthur(Johns Hopkins University), Chiara Scapoli(University of Ferrara), Raimund Erbel(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Karl‐Heinz Jöckel(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Susanne Moebus(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Ulf dé Fairé(Karolinska Institutet), Anders Hamsten(Karolinska Institutet), Michael Stümvoll(IFB Adiposity Diseases), Panagiotis Deloukas(Queen Mary University of London), Peter Donnelly(Centre for Human Genetics), Timothy M. Frayling(University of Exeter), Andrew T. Hattersley(University of Exeter), Samuli Ripatti(University of Helsinki), Veikko Salomaa(Finnish Institute for Health and Welfare), Nancy L. Pedersen(Karolinska Institutet), Bernhard O. Boehm(Nanyang Technological University), Richard N. Bergman(Cedars-Sinai Medical Center), Francis S. Collins(National Institutes of Health), Karen L. Mohlke(University of North Carolina at Chapel Hill), Jaakko Tuomilehto(Universität für Weiterbildung Krems), Torben Hansen(University of Copenhagen), Oluf Pedersen(University of Copenhagen), Inês Barroso(Wellcome Sanger Institute), Lars Lannfelt(Uppsala University), Erik Ingelsson(Uppsala University), Lars Lind(Uppsala University Hospital), Cecilia M. Lindgren(Broad Institute), Stéphane Cauchi(European Genomic Institute for Diabetes), Philippe Froguel(Centre National de la Recherche Scientifique), Ruth J. F. Loos(Child Health and Development Institute), Beverley Balkau(Université Paris-Sud), Heiner Boeing(German Institute of Human Nutrition), Paul W. Franks(Lund University), Aurelio Barricarte Gurrea(Instituto de Salud Pública de Navarra), Domenico Palli(Piedmont Reference Center for Epidemiology and Cancer Prevention), Yvonne T. van der Schouw(University Medical Center Utrecht), David Altshuler(Broad Institute), Leif Groop(Scania (Sweden)), Claudia Langenberg(MRC Epidemiology Unit), Nicholas J. Wareham(MRC Epidemiology Unit), Eric J.G. Sijbrands(Erasmus MC), Cornelia M. van Duijn(Erasmus MC), José C. Florez(Broad Institute), James B. Meigs(Broad Institute), Eric Boerwinkle(Baylor College of Medicine), Christian Gieger(Helmholtz Zentrum München), Konstantin Strauch(Helmholtz Zentrum München), Andres Metspalu(University of Tartu), Andrew D. Morris(Centre for Human Genetics), Colin N.A. Palmer(Ninewells Hospital), Frank B. Hu(Brigham and Women's Hospital), Unnur Þorsteinsdóttir(deCODE Genetics (Iceland)), Kāri Stefánsson(deCODE Genetics (Iceland)), Josée Dupuis(Boston University), Andrew P. Morris(Centre for Human Genetics), Michael Boehnke(University of Michigan), Mark I. McCarthy(Centre for Human Genetics), Inga Prokopenko(Centre for Human Genetics)
Diabetes
May 31, 2017
Cited by 807Open Access
Full Text

Abstract

To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel. Promising association signals were followed up in additional data sets (of 14,545 or 7,397 T2D case and 38,994 or 71,604 control subjects). We identified 13 novel T2D-associated loci (P < 5 × 10−8), including variants near the GLP2R, GIP, and HLA-DQA1 genes. Our analysis brought the total number of independent T2D associations to 128 distinct signals at 113 loci. Despite substantially increased sample size and more complete coverage of low-frequency variation, all novel associations were driven by common single nucleotide variants. Credible sets of potentially causal variants were generally larger than those based on imputation with earlier reference panels, consistent with resolution of causal signals to common risk haplotypes. Stratification of T2D-associated loci based on T2D-related quantitative trait associations revealed tissue-specific enrichment of regulatory annotations in pancreatic islet enhancers for loci influencing insulin secretion and in adipocytes, monocytes, and hepatocytes for insulin action–associated loci. These findings highlight the predominant role played by common variants of modest effect and the diversity of biological mechanisms influencing T2D pathophysiology.


Related Papers

No related papers found

Powered by citation graph analysis